canrenoic acid has been researched along with Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bos, R; Lechat, P; Médiani, O; Mougenot, N; Vanhoutte, PM | 1 |
| Araki, T; Ino, H; Mabuchi, H; Shimizu, M; Takeda, R; Yoshio, H | 1 |
2 other study(ies) available for canrenoic acid and Cardiomyopathies
| Article | Year |
|---|---|
Potassium canrenoate, an aldosterone receptor antagonist, reduces isoprenaline-induced cardiac fibrosis in the rat.
Topics: Animals; Blood Pressure; Canrenoic Acid; Cardiomyopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Heart Rate; Isoproterenol; Male; Mineralocorticoid Receptor Antagonists; Neurotransmitter Agents; Rats; Rats, Wistar | 2004 |
Effects of angiotensin-converting enzyme inhibitor and aldosterone antagonist on myocardial collagen in cardiomyopathic hamsters.
Topics: Aging; Animals; Body Weight; Canrenoic Acid; Captopril; Cardiomyopathies; Collagen; Cricetinae; Disease Models, Animal; Heart; Hydroxyproline; Male; Organ Size | 1995 |